1. Reduce time, labor, and costs in performing 2- hour OGTT |
2. Increase convenience for patients and providers with greater utilization |
3. Detect individuals at risk for progression to type 2 diabetes |
4. Identify individuals at high-risk for micro- and macro-vascular complications |
5. Identify individuals at high-risk for mortality |
6. Diagnose individuals with type 2 diabetes |
7. Identify antibody positive individuals at risk of developing type 1 diabetes for participation in prevention trials |
8. Diagnose gestational diabetes |
9. Predict adverse neonatal outcomes and infant development |
10. Identify pregnant women at high-risk of future type 2 diabetes and CVD |